other_material
confidence high
sentiment negative
materiality 0.85
Clearside Biomedical files Form 25 to complete Nasdaq delisting after Chapter 11 bankruptcy
Clearside Biomedical, Inc.
- Filed Form 25 on Dec 8, 2025 to delist from Nasdaq and deregister under Section 12(b); effective no earlier than Dec 18, 2025.
- Nasdaq delisting notice received Nov 24, 2025 after Chapter 11 filing (Case No. 25-12109); trading suspended Dec 1, 2025.
- Common stock trades on OTC Pink under symbol CLSDQ since Dec 1, 2025.
- Deregistration will reduce SEC reporting obligations 90 days after Form 25 effective date.